Skip to main content
Top
Published in: Digestive Diseases and Sciences 4/2018

01-04-2018 | Original Article

Clinicopathology and Survival in Patients with Gastroesophageal Reflux After Radical Surgery of Proximal Gastric Cancer

Authors: Ke-ming Ying, Zheng Chen, Cheng-xue Dang, Min-chang Sun, Gui-ru Yan, Bing-hua Kan, Zi-seng Xu

Published in: Digestive Diseases and Sciences | Issue 4/2018

Login to get access

Abstract

Background

Gastroesophageal reflux (GR) after radical resection of proximal gastric cancer (PGC) may influence survival; however, few studies have investigated survival in PGC patients who develop GR following radical resection. This study aimed to correlate the occurrence of GR after proximal gastrectomy (PG) and total gastrectomy (TG) with clinicopathological factors and long-term survival.

Methods

The PGC patient cohort was retrospectively grouped as follows: postoperative patients with and without GR (NGR). Clinicopathological characteristics and survival data were compared between the two groups.

Results

A total of 88 patients who underwent PG (53%) experienced postoperative GR; however, only 30 patients who underwent TG (14%) experienced GR (P = 0.000). The incidence of GR was significantly associated with surgical procedure (P < 0.01), tumor size (P < 0.01), infiltration depth (P < 0.01), lymph node metastasis (P = 0.018), postoperative distant metastasis (P < 0.01) and recurrence (P = 0.001). The 5-year overall survival of the GR group was significantly worse than that of the NGR group (39.3 vs. 46.5%, respectively; P = 0.046). The PG and TG groups had significantly different 5-year overall survival (45.2 vs. 50.9%, respectively; P = 0.047), and multivariate analysis revealed GR as an independent risk factor associated with poor overall survival.

Conclusions

Patients who experienced GR after radical resection for PGC were more likely to develop recurrence and metastasis, leading to shorter survival. TG for PGC was associated with a more favorable 5-year overall survival than was PG. Thus, TG should be performed for PGC patients with tumors larger than 5 cm, T3/T4 disease or lymph node metastasis to improve their long-term survival.
Literature
1.
go back to reference Saika K, Sobue T. Cancer statistics in the world. Gan To Kagaku Ryoho. 2013;40:2475–2480.PubMed Saika K, Sobue T. Cancer statistics in the world. Gan To Kagaku Ryoho. 2013;40:2475–2480.PubMed
2.
go back to reference Liu SZ, Wang B, Zhang F, et al. Incidence, survival and prevalence of esophageal and gastric cancer in Linzhou city from 2003 to 2009. Asian Pac J Cancer Prev. 2013;14:6031–6034.CrossRefPubMed Liu SZ, Wang B, Zhang F, et al. Incidence, survival and prevalence of esophageal and gastric cancer in Linzhou city from 2003 to 2009. Asian Pac J Cancer Prev. 2013;14:6031–6034.CrossRefPubMed
3.
go back to reference Fein M, Fuchs KH, Thalheimer A, Freys SM, Heimbucher J, Thiede A. Long-term benefits of Roux-en-Y pouch reconstruction after total gastrectomy: a randomized trial. Ann Surg. 2008;247:759–765.CrossRefPubMed Fein M, Fuchs KH, Thalheimer A, Freys SM, Heimbucher J, Thiede A. Long-term benefits of Roux-en-Y pouch reconstruction after total gastrectomy: a randomized trial. Ann Surg. 2008;247:759–765.CrossRefPubMed
4.
go back to reference Masuzawa T, Takiguchi S, Hirao M, et al. Comparison of perioperative and long-term outcomes of total and proximal gastrectomy for early gastric cancer: a multi-institutional retrospective study. World J Surg. 2014;38:1100–1106.CrossRefPubMed Masuzawa T, Takiguchi S, Hirao M, et al. Comparison of perioperative and long-term outcomes of total and proximal gastrectomy for early gastric cancer: a multi-institutional retrospective study. World J Surg. 2014;38:1100–1106.CrossRefPubMed
5.
go back to reference DeMeester TR, Wang CI, Wernly JA, et al. Technique, indications, and clinical use of 24hour esophageal pH monitoring. J Thorac Cardiovasc Surg. 1980;79:656–670.PubMed DeMeester TR, Wang CI, Wernly JA, et al. Technique, indications, and clinical use of 24hour esophageal pH monitoring. J Thorac Cardiovasc Surg. 1980;79:656–670.PubMed
6.
go back to reference Devesa SS, Fraumeni JF. The rising incidence of gastric cardia cancer. J Natl Cancer Inst. 1999;91:747–749.CrossRefPubMed Devesa SS, Fraumeni JF. The rising incidence of gastric cardia cancer. J Natl Cancer Inst. 1999;91:747–749.CrossRefPubMed
7.
go back to reference Matsuhisa T, Aftab H. Observation of gastric mucosa in Bangladesh, the country with the lowest incidence of gastric cancer, and japan, the country with the highest incidence. Helicobacter. 2012;17:396–401.CrossRefPubMedPubMedCentral Matsuhisa T, Aftab H. Observation of gastric mucosa in Bangladesh, the country with the lowest incidence of gastric cancer, and japan, the country with the highest incidence. Helicobacter. 2012;17:396–401.CrossRefPubMedPubMedCentral
8.
go back to reference Bondar VG, Baker I, Zaika AN. Subcardial resection for gastric cancer. Klin Khir. 2005;7:5–8. Bondar VG, Baker I, Zaika AN. Subcardial resection for gastric cancer. Klin Khir. 2005;7:5–8.
9.
go back to reference Wang Z, Zhang X, Hu J, et al. Predictive factors for lymph node metastasis in early gastric cancer with signet ring cell histology and their impact on the surgical strategy: analysis of single institutional experience. J Surg Res. 2014;191:130–133.CrossRefPubMed Wang Z, Zhang X, Hu J, et al. Predictive factors for lymph node metastasis in early gastric cancer with signet ring cell histology and their impact on the surgical strategy: analysis of single institutional experience. J Surg Res. 2014;191:130–133.CrossRefPubMed
10.
go back to reference Huang CM, Zhang XF, Lu HS, et al. Long-term therapeutic effects of total gastrectomy in cancer of the cardia and stomach fundus. Zhonghua Wai Ke Za Zhi. 2003;41:729–732.PubMed Huang CM, Zhang XF, Lu HS, et al. Long-term therapeutic effects of total gastrectomy in cancer of the cardia and stomach fundus. Zhonghua Wai Ke Za Zhi. 2003;41:729–732.PubMed
11.
go back to reference Kim JH, Park SS, Kim J, et al. Surgical outcomes for gastric cancer in the upper third of the stomach. World J Surg. 2006;30:1870–1876. discussion 1877.CrossRefPubMed Kim JH, Park SS, Kim J, et al. Surgical outcomes for gastric cancer in the upper third of the stomach. World J Surg. 2006;30:1870–1876. discussion 1877.CrossRefPubMed
12.
go back to reference Ding J, Liao GQ, Yan ZS, et al. Meta-analysis of proximal gastrectomy and total gastrectomy for cancer of cardia and fundus. Zhong Nan DaXue Xue Bao Yi Xue Ban. 2011;36:570–575. Ding J, Liao GQ, Yan ZS, et al. Meta-analysis of proximal gastrectomy and total gastrectomy for cancer of cardia and fundus. Zhong Nan DaXue Xue Bao Yi Xue Ban. 2011;36:570–575.
13.
go back to reference Yamamoto M, Rashid OM, Wong J. Surgical management of gastric cancer: the East vs. West perspective. J Gastrointest Oncol. 2015;6:79–88.PubMedPubMedCentral Yamamoto M, Rashid OM, Wong J. Surgical management of gastric cancer: the East vs. West perspective. J Gastrointest Oncol. 2015;6:79–88.PubMedPubMedCentral
14.
go back to reference Shiraishi N, Inomata M, Osawa N, Yasuda K, Adachi Y, Kitano S. Early and late recurrence after gastrectomy for gastric carcinoma. Univariate and multivariate analyses. Cancer. 2000;89:255–261.CrossRefPubMed Shiraishi N, Inomata M, Osawa N, Yasuda K, Adachi Y, Kitano S. Early and late recurrence after gastrectomy for gastric carcinoma. Univariate and multivariate analyses. Cancer. 2000;89:255–261.CrossRefPubMed
15.
go back to reference Maeda K, Kang SM, Onoda N, et al. Vascular endothelial growth factor expression in preoperative biopsy specimens correlates with disease recurrence in patients with early gastric carcinoma. Cancer. 1999;86:566–571.CrossRefPubMed Maeda K, Kang SM, Onoda N, et al. Vascular endothelial growth factor expression in preoperative biopsy specimens correlates with disease recurrence in patients with early gastric carcinoma. Cancer. 1999;86:566–571.CrossRefPubMed
16.
go back to reference Adachi Y, Suematsu T, Shiraishi N, Tanimura H, Morimoto A, Kitano S. Perigastric lymph node status as a prognostic indicator in patients with gastric cancer. Br J Surg. 1998;85:1281–1284.CrossRefPubMed Adachi Y, Suematsu T, Shiraishi N, Tanimura H, Morimoto A, Kitano S. Perigastric lymph node status as a prognostic indicator in patients with gastric cancer. Br J Surg. 1998;85:1281–1284.CrossRefPubMed
17.
go back to reference Association Japanese Gastric Cancer. Japanese gastric cancer treatment guidelines 2010 (ver. 3). Gastric Cancer. 2011;14:113–123.CrossRef Association Japanese Gastric Cancer. Japanese gastric cancer treatment guidelines 2010 (ver. 3). Gastric Cancer. 2011;14:113–123.CrossRef
18.
go back to reference Wu CW, Hsieh MC, Lo SS, Tsay SH, Lui WY, P’eng FK. Relation of number of positive lymphnodes to the prognosis of patients with primary gastric adenocarcinoma. Gut. 1996;38:525–527.CrossRefPubMedPubMedCentral Wu CW, Hsieh MC, Lo SS, Tsay SH, Lui WY, P’eng FK. Relation of number of positive lymphnodes to the prognosis of patients with primary gastric adenocarcinoma. Gut. 1996;38:525–527.CrossRefPubMedPubMedCentral
19.
go back to reference Japanese Gastric Cancer Association. Japanese classification of gastric carcinoma. Gastric Cancer. 2011;14:101–112.CrossRef Japanese Gastric Cancer Association. Japanese classification of gastric carcinoma. Gastric Cancer. 2011;14:101–112.CrossRef
20.
go back to reference Chang AT, Ng WT, Law AL, Ku KM, Lee MC, Lee AW. Adjuvant chemoradiation for resected gastric cancer: a 10-year experience. Gastric Cancer. 2011;14:63–71.CrossRefPubMed Chang AT, Ng WT, Law AL, Ku KM, Lee MC, Lee AW. Adjuvant chemoradiation for resected gastric cancer: a 10-year experience. Gastric Cancer. 2011;14:63–71.CrossRefPubMed
21.
go back to reference Chen L, Zhang Y, Wei B, Zhao XY, Li T. Surgical treatment for patients with gastric cancer: report of 2335 cases. Zhonghua Wei Chang Wai Ke Za Zhi. 2007;10:421–424.PubMed Chen L, Zhang Y, Wei B, Zhao XY, Li T. Surgical treatment for patients with gastric cancer: report of 2335 cases. Zhonghua Wei Chang Wai Ke Za Zhi. 2007;10:421–424.PubMed
22.
go back to reference Rosa F, Alfieri S, Tortorelli AP, Fiorillo C, Costamagna G, Doglietto GB. Trends in clinical features, postoperative outcomes, and long-term survival for gastric cancer: a Western experience with 1,278 patients over 30 years. World J Surg Oncol. 2014;12:217.CrossRefPubMedPubMedCentral Rosa F, Alfieri S, Tortorelli AP, Fiorillo C, Costamagna G, Doglietto GB. Trends in clinical features, postoperative outcomes, and long-term survival for gastric cancer: a Western experience with 1,278 patients over 30 years. World J Surg Oncol. 2014;12:217.CrossRefPubMedPubMedCentral
23.
go back to reference Merrett ND. Multimodality treatment of potentially curative gastric cancer: geographical variations and future prospects. World J Gastroenterol. 2014;20:12892–12899.CrossRefPubMedPubMedCentral Merrett ND. Multimodality treatment of potentially curative gastric cancer: geographical variations and future prospects. World J Gastroenterol. 2014;20:12892–12899.CrossRefPubMedPubMedCentral
24.
go back to reference Richter JE. Gastroesophageal reflux disease treatment: side effects and complications of fundoplication. Clin Gastroenterol Hepatol. 2013;11:465–471. quiz e39.CrossRefPubMed Richter JE. Gastroesophageal reflux disease treatment: side effects and complications of fundoplication. Clin Gastroenterol Hepatol. 2013;11:465–471. quiz e39.CrossRefPubMed
25.
go back to reference Sakuramoto S, Yamashita K, Kikuchi S, et al. Clinical experience of laparoscopy-assisted proximal gastrectomy with Toupet-like partial fundoplication in early gastric cancer for preventing reflux esophagitis. J Am Coll Surg. 2009;209:344–351.CrossRefPubMed Sakuramoto S, Yamashita K, Kikuchi S, et al. Clinical experience of laparoscopy-assisted proximal gastrectomy with Toupet-like partial fundoplication in early gastric cancer for preventing reflux esophagitis. J Am Coll Surg. 2009;209:344–351.CrossRefPubMed
26.
go back to reference Wen L, Chen XZ, Wu B, et al. Total VS. proximal gastrectomy for proximal gastric cancer: a systematic review and meta-analysis. Hepatogastroenterology. 2012;59:633–640.PubMed Wen L, Chen XZ, Wu B, et al. Total VS. proximal gastrectomy for proximal gastric cancer: a systematic review and meta-analysis. Hepatogastroenterology. 2012;59:633–640.PubMed
27.
go back to reference Liu Y, Han G, Wang G, et al. Proximal gastrectomy versus total gastrectomy for adenocarcinoma of esophagogastric junction: a meta-analysis. Zhonghua Wei Chang Wai Ke Za Zhi. 2014;17:373–377.PubMed Liu Y, Han G, Wang G, et al. Proximal gastrectomy versus total gastrectomy for adenocarcinoma of esophagogastric junction: a meta-analysis. Zhonghua Wei Chang Wai Ke Za Zhi. 2014;17:373–377.PubMed
28.
go back to reference Fedeli U, Schievano E, Lisiero M. Mortality after esophageal and gastric cancer resection. World J Surg. 2012;36:2630–2636.CrossRefPubMed Fedeli U, Schievano E, Lisiero M. Mortality after esophageal and gastric cancer resection. World J Surg. 2012;36:2630–2636.CrossRefPubMed
Metadata
Title
Clinicopathology and Survival in Patients with Gastroesophageal Reflux After Radical Surgery of Proximal Gastric Cancer
Authors
Ke-ming Ying
Zheng Chen
Cheng-xue Dang
Min-chang Sun
Gui-ru Yan
Bing-hua Kan
Zi-seng Xu
Publication date
01-04-2018
Publisher
Springer US
Published in
Digestive Diseases and Sciences / Issue 4/2018
Print ISSN: 0163-2116
Electronic ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-018-4960-4

Other articles of this Issue 4/2018

Digestive Diseases and Sciences 4/2018 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.